Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 218-645-3 | CAS number: 2210-79-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Dermal absorption
Administrative data
- Endpoint:
- dermal absorption in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The study was reported in a peer-reviewed journal without GLP compliance.
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 2 000
- Report date:
- 1999
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- Penetration of the test substance as measured by diffusion cell through rat, mouse and human skin samples with detection by Liquid Snitillation counting and HPLC analysis.
- GLP compliance:
- no
Test material
- Reference substance name:
- 2,3-epoxypropyl o-tolyl ether
- EC Number:
- 218-645-3
- EC Name:
- 2,3-epoxypropyl o-tolyl ether
- Cas Number:
- 2210-79-9
- Molecular formula:
- C10H12O2
- IUPAC Name:
- oxirane
- Reference substance name:
- Oxirane, 2-[(2-methylphenoxy)methyl]-
- IUPAC Name:
- Oxirane, 2-[(2-methylphenoxy)methyl]-
- Reference substance name:
- o-Cresyl glycidyl ether (o-CGE).
- IUPAC Name:
- o-Cresyl glycidyl ether (o-CGE).
- Test material form:
- other: Liquid at room temperature.
- Details on test material:
- As per IUCLID5 Sections 1.1, 1.2, 1.3 and the publication.
Constituent 1
Constituent 2
Constituent 3
- Radiolabelling:
- yes
Test animals
- Species:
- other: Rat, mouse and human skin samples
- Strain:
- other: Fisher 344 rats and C3H mice
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Male Fisher 344 rats (~ 250 gm) and male C3H mice (~ 25 gm) were from the Central Laboratories for the Blood Banks (CLB) (Amsterdam, The Netherlands). Animals were kept on a 12 h light/dark cycle in humidity- (60±15% relative humidity) and temperature- (22±2 °C) controlled mass-air-displacement rooms. A standard rodent diet (VRF-I, Broekman Institunt [Charles Rivet Laboratories], Someren, The Netherlands) and de—ionized water were supplied ad libitum. Following an acclimation of 1 week, the animals were used as the source for viable rodent skin. Fresh full-thickness healthy human breast skin was from five female Caucasian patients, aged 17-41.
Administration / exposure
- Type of coverage:
- other: Open and occluded.
- Vehicle:
- acetone
- Duration of exposure:
- 24 hr.
- Doses:
- ~ 635 mM.
- No. of animals per group:
- There were 3-4 diffusion cells per skin sample.
- Control animals:
- no
- Details on study design:
- The skin samples were mounted, epidermis uppermost, in a flow-through diffusion cell system. . The system consisted of (1) 12 stainless steel diffusion cells, which were stirred continuously with magnetic stirrer bars (Variomag HP 15 Multipoint, HP Labortechnik, Munich, Germany) to prevent irregular penetration due to air bubbles underneath the skin membrane, (2) a fraction collector holding 20 ml glass scintillation vials, (3) a thermostatically controlled water circulator (PolyScience, USA) to heat the jackets holding the cells in such a way that the skin surface temperature was kept at 12± 1 °C, and (4) a cassette peristaltic pump (Watson Marlow, Falmouth, UK). The exposed skin surface was ~ 0.635 cm2. The underside of the skin was exposed to continuously flowing (flow rate 1.5 ml/h) receptor fluid consisting of Hanks’ balanced salt solution, without phenol red and sodium bicarbonate, buffered with 25 mM HEPES (pH 7.40) and containing 2.5% v/v BSA and 50 ug gentamicin per ml. The receptor fluid was transported to the cells and from the cells, through the pump, to the fraction collector through PVC tubing (Accurated tubing, Elkay). In some experiments the cells were occluded by placing a polycarbonate lid over the cells.
- Details on in vitro test system (if applicable):
- Three different skin donors (both for human and rodent skin) were used for each of the study Human skin was dissected from the tissue removed during mammoplastic reduction surgery using a scalpel and cleaned with physiological saline. The shaved area from the rodent skin was cut out with dissecting scissors. Excess subcutaneous tissue was removed front the skin samples with a scalpel. The skin was placed on a Teflon dissecting board and full-thickness skin circles were cut out using a circular sharpened steel cutter. Mouse skin was always used at full thickness since it is so thin that it can not be derniatomed. Human and rat skin was only used following dermatomization. The skin, epidermis up, was stretched over a small band of Teflon and a sheet of skin was cut off using a hand-held keratotome (Storz Instrument Co., US). Skin circles were cut out of this sheet using small dissection scissors. The gross integrity of the skin was assessed visually.
In the experiment, which was carried out in triplicate, three-to-four diffusion cells with skin from the same donor (human or animal) were used to study the penetration of each of o-CGE. Aliquots of 5.0 ul o-CGE dissolved in acetone at a concentration of ~ 635 mM were applied to the exposed skin surface using a niicropipette (final concentration 5.0 umol/cm2). The receptor fluid was collected in 3-hourly fractions for 24 h following application of the test substance. The fractions-were weighed for determination of the actual flow rates and the radioactivity in an aliquot of the fractions was determined by LSC. The remaining portions of the collected fractions were extracted twice with a double volume of ethyl acetate. An aliquot of DMSO was added to the combined fractions and a gentle stream of nitrogen evaporated the ethyl acetate. The DMSO residue was mixed with an equal volume of methanol and subsequently analysed by HPLC with radiodetection.
Results and discussion
- Signs and symptoms of toxicity:
- not specified
- Remarks:
- The test system was in vitro skin.
- Dermal irritation:
- not specified
- Remarks:
- The test system was in vitro skin.
- Total recovery:
- 13 +/- 3 to 26 +/- 5%.
Any other information on results incl. tables
With o-CGE, the dermal penetration reached a plateau at absorption of ~ 10, 18 and 23 % of the applied dose with human, rat and mouse skin respectively. In all three cases, the curves started levelling off after ~ 12 hr. Occlusion of the skin significantly enhanced the dermal penetration of o-CGE through human, rat as well as mouse skin: the percentage of the applied dose that had penetrated through the skin was roughly doubled by occlusion. Based upon absorption rate constant human skin was 1.4 -2 -fold less permeable to o-CGE.
For o-CGE, a considerable amount of the penetrated dose (86—88 %), was hydrolysed to mephenesin (the glycerol ether of o-cresol) during the first hours of penetration in human, rat as well as mouse skin, but as the study progressed less o-CGE was hydrolysed and more unchanged compound was recovered from the receptor fluid. Little or no diol was detected.
Applicant's summary and conclusion
- Conclusions:
- Only approximately 10-22% of the applied dose of o-CGE (2,3-epoxypropyl o-tolyl ether ) penetrated the skin samples. Furthermore total recovery was 13-26%. The low perneability and recovery of o-CGE is believed to be due to its volatility. Occlusion of the diffusion cells resulted in an approximately doubling of the precent absorption.
Approximately 86-88% of the penetrated dose of o-CGE was hydrolysed to mephenesin (the glycerol ether of o-cresol) during the first hours of penetration in human, rat as well as mouse skin. - Executive summary:
The test substance, 2,3-epoxypropylo-tolyl ether ( o-Cresyl glycidyl ether/o-CGE) was assessed for dermal penetration in vitro in diffusion cells with human, rat and mouse skin samples. Only approximately 10-22% of the applied dose of o-CGE (2,3-epoxypropyl o-tolyl ether ) penetrated the skin samples. Furthermore, total recovery was only13-26%. The low perneability and recovery of o-CGE is believed to be due to its volatility. Occlusion of the diffusion cells resulted in an approximately doubling of the precent absorption. Approximately 86-88% of the penetrated dose of o-CGE was hydrolysed to mephenesin (the glycerol ether of o-cresol) during the first hours of penetration in human, rat as well as mouse skin.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.